Real-world attrition rates after second-line therapy or later in patients from the flatiron database with relapsed/refractory multiple myeloma refractory to lenalidomide

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

Cited 0|Views12
No score
Key words
relapsed/refractory multiple myeloma relapsed/refractory,multiple myeloma,lenalidomide,second-line second-line therapy,attrition rates,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined